Author

Kei‐ichi Takata

Institute for Basic ScienceORCID 0000-0002-8272-3397Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Changwook LeeiD· 1 shared Dayoung KimiD· 1 shared Dean G. TangiD· 1 shared Enkhzul AmarsanaaiD· 1 shared Eun A LeeiD· 1 shared Hongtae KimiD· 1 shared Hsueh‐Ping ChaoiD· 1 shared Ja Yil LeeiD· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Changwook LeeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MSH2-MSH3 promotes DNA end resection during HR and blocks TMEJ through interaction with SMARCAD1 and EXO1

Jung‐Min Oh, Yujin Kang, Jumi Park, Yubin Sung, Dayoung Kim, Yuri Seo, Eun A Lee, Jae Sun Ra, Enkhzul Amarsanaa, Young‐Un Park, Hongtae Kim, Orlando D. Schärer, Seung Woo Cho, Changwook Lee, Kei‐ichi Takata, , Kyungjae Myung

This study identifies MSH2-MSH3's role in promoting DNA end resection during HR and inhibiting TMEJ by interacting with SMARCAD1 and EXO1.

bioRxiv · Apr 23, 2021 · PreprintMolecular Biology

FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells

Junya Tomida, Kei‐ichi Takata, Sarita Bhetawal, Maria D. Person, Hsueh‐Ping Chao, Dean G. Tang, Richard Dean Wood

This study identifies FAM35A as a REV7-associated protein that modulates DNA damage responses, showing altered expression in prostate cancer and resistance to PARP inhibitors in BRCA1-defective cells.

The EMBO Journal · May 22, 2018Peer-reviewedMolecular Biology